Abstract
Objective The purpose of this study was to determine the ex vivo human placental transfer of rifampin and rifabutin. Methods Seven placentas from uncomplicated, term vaginal or cesarean deliveries were studied utilizing the ex vivo single cotyledon perfusion system. Antipyrine was used for the reference compound in the determination of the clearance indices of rifampin and rifabutin. Results The clearance indices of rifampin at maternal concentrations of 1.0 and 10.0 μg/ml were 0.12 ± 0.05 and 0.12 ± 0.11, respectively. The clearance indices of rifabutin at maternal concentrations of 1.0 and 10.0 μg/ml were 0.44 ± 0.11 and 0.37 ± 0.15, respectively. Conclusions Because of its greater lipophilicity, rifabutin was found to have a greater clearance than rifampin. However, because of rifabutin's trend toward greater deposition in tissue, there was proportionately less accumulation of rifabutin in the fetal circulation when compared to rifampin. Infect. Dis. Obstet. Gynecol. 4:319–322, 1996. © 1997 Wiley-Liss, Inc.
Highlights
The clearance indices of rifampin at maternal concentrations of 1.0 and 10.0 pg/ml were 0.12 0.05 and 0.12 0.11, respectively
Determinations of the clearance indices of rifampin and rifabutin revealed that rifabutin had a significantly higher clearance index than that of rifampin at both the 1.0 and 10.0 pg/ml concentrations (Table 1)
There was no significant difference between rifampin’s or rifabutin’s accumulation in the fetal compartment (Table 2)
Summary
Seven placentas from uncomplicated, term vaginal or cesarean deliveries were studied utilizing the ex vivo single cotyledon perfusion system. Antipyrine was used for the reference compound in the determination of the clearance indices of rifampin and rifabutin
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
